Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAPL Apple	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$224.23	$236.00	Hold
ABBV AbbVie	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$171.10 -1.9%	$231.00 ➝ $224.00	Overweight ➝ Overweight
ABBV AbbVie	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$171.10 -1.9%	$228.00 ➝ $208.00	Outperform ➝ Outperform
ABBV AbbVie	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Verdult Subscribe to MarketBeat All Access for the recommendation accuracy rating	$171.10 -1.9%	$226.00 ➝ $215.00	Buy ➝ Buy
ABNB Airbnb	Reiterated by	Phillip Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$133.20 -3.1%	$120.00	Neutral ➝ Reduce
ACLX Arcellx	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$100.48 -5.7%	$87.00 ➝ $136.00	Buy ➝ Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ADM Archer-Daniels-Midland	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.44 -1.8%	$57.00 ➝ $52.00	Equal Weight ➝ Equal Weight
AEO American Eagle Outfitters	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.94 -1.5%	$22.00 ➝ $19.00	Hold ➝ Hold
AESI Atlas Energy Solutions	Downgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.49 -2.4%	$23.00 ➝ $19.00	Overweight ➝ Equal Weight
AFG American Financial Group	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$143.53 +0.9%	$135.00 ➝ $150.00	Neutral ➝ Neutral
AGEN Agenus	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Bodnar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.11 -20.5%	$8.00 ➝ $7.00	Neutral ➝ Neutral
AGL agilon health	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.87 -13.9%	$7.00 ➝ $2.00	Hold ➝ Hold
AGYS Agilysys	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$123.75 +0.7%	$120.00 ➝ $135.00	Outperform ➝ Outperform
AIG American International Group	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.87 -0.7%	$88.00 ➝ $87.00	Outperform ➝ Outperform
AIZ Assurant	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$212.31 +0.7%	$194.00 ➝ $212.00	Market Perform ➝ Market Perform
AJG Arthur J. Gallagher & Co.	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$295.20 +0.8%	$312.00 ➝ $325.00	Outperform ➝ Outperform
AL Air Lease	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.38 +0.0%	$52.00 ➝ $56.00	Overweight ➝ Overweight
ALB Albemarle	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.90 -6.9%	$132.00 ➝ $127.00	Overweight ➝ Overweight
ALB Albemarle	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$102.90 -6.9%	$108.00 ➝ $133.00	Outperform ➝ Outperform
ALGM Allegro MicroSystems	Initiated by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.52 -1.6%	$30.00	Buy
ALNY Alnylam Pharmaceuticals	Downgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$268.95 -3.9%		Peer Perform ➝ Underperform
ALT Altimmune	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.49 +29.1%	$26.00	Buy
ALXO ALX Oncology	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.34 -9.5%		Overweight
AMAT Applied Materials	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$186.61 -1.0%	$270.00 ➝ $250.00	Buy ➝ Buy
AMCX AMC Networks	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.48 -3.0%	$10.00 ➝ $9.00	Underweight ➝ Underweight
AMGN Amgen	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$298.84 -7.1%		Outperform
AMGN Amgen	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$298.84 -7.1%	$380.00 ➝ $380.00	Buy ➝ Buy
ANAB AnaptysBio	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.50 -4.0%	$75.00 ➝ $66.00	Overweight ➝ Overweight
APGE Apogee Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.35 -5.1%	$87.00	Outperform
ARCB ArcBest	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$116.91 -4.1%	$110.00 ➝ $127.00	Neutral ➝ Neutral
ARDT Ardent Health Partners	Target Raised by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.17 -0.8%	$23.00 ➝ $25.00	Outperform ➝ Outperform
ARGX argenx	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$593.95 +0.9%	$697.00	Peer Perform ➝ Outperform
ARMK Aramark	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.03 -1.7%	$38.00 ➝ $44.00	Neutral ➝ Neutral
ARMK Aramark	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.03 -1.7%	$38.00 ➝ $40.00	Equal Weight ➝ Equal Weight
ARMK Aramark	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.03 -1.7%	$41.00 ➝ $45.00	Overweight ➝ Overweight
ARMK Aramark	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Bibb Subscribe to MarketBeat All Access for the recommendation accuracy rating	$38.03 -1.7%	$42.00 ➝ $46.00	Buy ➝ Buy
ARMK Aramark	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.03 -1.7%	$43.00 ➝ $45.00	Buy ➝ Buy
ARMP Armata Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.75 +22.2%	$7.00 ➝ $7.00	Buy ➝ Buy
AS Amer Sports	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.96 -3.0%	$19.00 ➝ $24.00	Buy ➝ Buy
ASPN Aspen Aerogels	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.80 -8.5%	$27.00 ➝ $25.00	Overweight ➝ Overweight
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here
ATLC Atlanticus	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	V. Caintic Subscribe to MarketBeat All Access for the recommendation accuracy rating	$44.50 +0.7%	$45.00 ➝ $54.00	Buy ➝ Buy
ATMU Atmus Filtration Technologies	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.56 +0.4%	$42.00 ➝ $48.00	Outperform ➝ Outperform
ATMU Atmus Filtration Technologies	Target Raised by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.56 +0.4%	$49.00 ➝ $50.00	Outperform ➝ Outperform
AVAV AeroVironment	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$218.03 -7.3%	$240.00 ➝ $240.00	Buy ➝ Hold
AVBH Avidbank	Upgraded by	Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Coffey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.98 +1.3%	$26.00	Neutral ➝ Buy
AVBH Avidbank	Upgraded by	Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Coffey Subscribe to MarketBeat All Access for the recommendation accuracy rating	$21.98 +1.3%	$26.00	Neutral ➝ Buy
AVDL Avadel Pharmaceuticals	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.15 -19.3%	$22.00 ➝ $22.00	Buy ➝ Buy
AVPT AvePoint	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.85 +1.0%	$7.50 ➝ $15.00	Neutral ➝ Neutral
AXSM Axsome Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Fadia Subscribe to MarketBeat All Access for the recommendation accuracy rating	$99.49 +9.4%	$130.00 ➝ $130.00	Buy ➝ Buy
BABA Alibaba Group	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$91.78 -3.8%	$92.00 ➝ $113.00	Outperform ➝ Outperform
BE Bloom Energy	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.55 -0.5%	$13.00 ➝ $16.00	Positive ➝ Positive
BIDU Baidu	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$84.80 -3.9%	$130.00 ➝ $115.00	Outperform ➝ Outperform
BILI Bilibili	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.08 -7.3%	$17.00 ➝ $21.00	Outperform ➝ Outperform
BILL BILL	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Nance Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.06 +3.7%	$60.00 ➝ $77.00	Neutral ➝ Neutral
BJ BJ's Wholesale Club	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Kelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	$89.06 -0.6%	$92.00 ➝ $100.00	Overweight ➝ Overweight
BKE Buckle	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.61 +5.5%	$31.00 ➝ $46.00	Sell ➝ Neutral
BLMN Bloomin' Brands	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.35 -3.0%	$19.00 ➝ $14.00	Neutral ➝ Neutral
BLNK Blink Charging	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Legg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.78 -2.7%	$5.00 ➝ $5.00	Buy ➝ Buy
BMY Bristol-Myers Squibb	Upgraded by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.02 -1.3%	$55.00 ➝ $73.00	Market Perform ➝ Outperform
BMY Bristol-Myers Squibb	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.02 -1.3%	$36.00 ➝ $39.00	Underweight ➝ Underweight
BMY Bristol-Myers Squibb	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Verdult Subscribe to MarketBeat All Access for the recommendation accuracy rating	$59.02 -1.3%	$55.00 ➝ $60.00	Neutral ➝ Neutral
BMY Bristol-Myers Squibb	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.02 -1.3%	$57.00 ➝ $61.00	Market Perform ➝ Market Perform
BRDG Bridge Investment Group	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Katz Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.81 -3.4%	$10.50 ➝ $10.00	Hold ➝ Hold
BRX Brixmor Property Group	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.74 -0.8%	$28.00 ➝ $32.00	Overweight ➝ Overweight
BRZE Braze	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.70 -0.1%	$65.00 ➝ $47.00	Buy ➝ Buy
BWXT BWX Technologies	Upgraded by	Alembic Global Advisors Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.85 +0.3%	$148.00	Neutral ➝ Overweight
CABO Cable One	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$402.41 -0.3%	$480.00 ➝ $470.00	Neutral ➝ Neutral
CACI CACI International	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$567.39 -0.9%	$610.00 ➝ $625.00	Overweight ➝ Overweight
CGON CG Oncology	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.98 -6.8%	$75.00 ➝ $75.00	Buy ➝ Buy
CHRW C.H. Robinson Worldwide	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$109.09 +0.1%	$110.00 ➝ $127.00	Neutral ➝ Buy
CLMB Climb Global Solutions	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$121.16 +0.9%	$90.00 ➝ $136.00	Outperform ➝ Outperform
CMBM Cambium Networks	Target Lowered by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.27 +1.6%	$5.00 ➝ $3.00	Outperform ➝ Outperform
CMG Chipotle Mexican Grill	Reiterated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Salera Subscribe to MarketBeat All Access for the recommendation accuracy rating	$60.49 +2.1%	$65.00 ➝ $65.00	Equal Weight ➝ Equal Weight
CMPO CompoSecure	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.23 +0.7%	$17.00 ➝ $17.00	Buy ➝ Buy
CMTG Claros Mortgage Trust	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.13 -6.3%	$6.75 ➝ $7.25	Underperform ➝ Underperform
CNI Canadian National Railway	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$111.57 -0.1%	$126.00 ➝ $130.00	Neutral ➝ Buy
COGT Cogent Biosciences	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.38 -0.2%	$11.00	Neutral
CP Canadian Pacific Kansas City	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$76.90 -0.6%	$98.00 ➝ $91.00	Buy ➝ Buy
CRI Carter's	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$52.42 -0.5%	$50.00 ➝ $50.00	Sell ➝ Neutral
CRM Salesforce	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$341.20 -0.2%	$275.00 ➝ $330.00	Equal Weight ➝ Equal Weight
CRUS Cirrus Logic	Initiated by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$104.67 0.0%	$130.00	Buy
CSX CSX	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$36.13 -1.1%	$42.00 ➝ $44.00	Buy ➝ Buy
CTXR Citius Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.48 +6.6%	$4.00 ➝ $4.00	Buy ➝ Buy
CXM Sprinklr	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.21 -1.0%	$8.00 ➝ $6.00	Equal Weight ➝ Underweight
DAC Danaos	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$82.69 +1.9%	$105.00 ➝ $105.00	Buy ➝ Buy
DADA Dada Nexus	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.56 -8.8%	$4.50 ➝ $4.00	Outperform ➝ Outperform
DAL Delta Air Lines	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.06 +0.8%	$59.00 ➝ $75.00	Buy ➝ Buy
DASH DoorDash	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$176.49 +0.9%	$170.00 ➝ $200.00	Buy ➝ Buy
DDI DoubleDown Interactive	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.20 -4.7%	$16.25 ➝ $21.00	Outperform ➝ Outperform
DDI DoubleDown Interactive	Target Raised by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.20 -4.7%	$18.00 ➝ $21.00	Outperform ➝ Outperform
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here
DFY Definity Financial	Downgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$55.01 0.0%	C$53.00 ➝ C$55.00	Outperform ➝ Market Perform
DIS Walt Disney	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$101.02 +0.2%	$105.00 ➝ $128.00	Outperform ➝ Outperform
DKNG DraftKings	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.71 -3.5%	$50.00 ➝ $55.00	Buy ➝ Buy
DLR Digital Realty Trust	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$180.72 -1.2%	$168.00 ➝ $202.00	Buy ➝ Buy
DNUT Krispy Kreme	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.31 -2.6%	$14.00 ➝ $13.00	Overweight ➝ Overweight
ECN ECN Capital	Target Raised by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$2.96 -1.3%	C$2.25 ➝ C$3.50
EE Excelerate Energy	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Blum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.96 +0.2%	$19.00 ➝ $22.00	Underweight ➝ Underweight
EIF Exchange Income	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$55.55 +0.8%	C$70.00 ➝ C$72.00
ELS Equity LifeStyle Properties	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.24 -0.4%	$70.00 ➝ $71.00	Hold ➝ Hold
EMP.A Empire	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$41.48 +1.2%	C$42.00 ➝ C$46.00
EMX EMX Royalty	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.75 +0.6%	$6.75 ➝ $7.00	Buy ➝ Buy
ENPH Enphase Energy	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$60.09 -5.6%	$95.00 ➝ $76.00	Hold ➝ Hold
EOG EOG Resources	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Dingmann Subscribe to MarketBeat All Access for the recommendation accuracy rating	$133.10	$115.00 ➝ $135.00	Hold ➝ Hold
EOG EOG Resources	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$133.10		Hold
ERE.UN European Residential Real Estate Investment Trust	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$3.52 +1.1%	C$3.75 ➝ C$4.25	Buy
EVE EVe Mobility Acquisition	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.30 +0.5%	$5.50 ➝ $5.00	Overweight ➝ Overweight
EVH Evolent Health	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.44 -4.6%	$20.00 ➝ $20.00	Outperform ➝ Outperform
FATE Fate Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.38 -7.0%	$5.00	Neutral
FDX FedEx	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$287.32 -0.9%	$301.00 ➝ $331.00	Buy ➝ Buy
FEMY Femasys	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.03 -12.0%	$12.00 ➝ $12.00	Buy ➝ Buy
FF First Mining Gold	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$0.14	C$0.80 ➝ C$0.35
FIGS FIGS	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.71 -0.8%	$5.00 ➝ $4.00	Equal Weight ➝ Equal Weight
FIVN Five9	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.27 -1.0%	$55.00 ➝ $40.00	Overweight ➝ Equal Weight
FLR Fluor	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.50 -2.6%	$58.00 ➝ $65.00	Buy ➝ Buy
FM First Quantum Minerals	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$18.88 -0.4%		Equal Weight ➝ Overweight
FMBH First Mid Bancshares	Downgraded by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.40 -1.9%	$44.00 ➝ $47.00	Buy ➝ Neutral
FOLD Amicus Therapeutics	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.49 -1.9%	$16.00 ➝ $17.00	Overweight ➝ Overweight
FRT Federal Realty Investment Trust	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.65 -1.1%	$121.00 ➝ $122.00	Neutral ➝ Neutral
FVR FrontView REIT	Initiated by	Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.13 +0.8%	$22.00	Overweight
GAU Galiano Gold	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.43 +2.1%	$4.20 ➝ $4.60	Buy ➝ Buy
GENI Genius Sports	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.48 +17.3%	$9.00 ➝ $9.00	Buy ➝ Buy
GLP Global Partners	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.49 -1.6%	$51.00 ➝ $54.00	Buy ➝ Buy
GPMT Granite Point Mortgage Trust	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.27 -3.5%	$2.75 ➝ $3.00	Underperform ➝ Underperform
GRAB Grab	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.89 +11.6%	$5.00 ➝ $5.70	Overweight ➝ Overweight
GRAB Grab	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.89 +11.6%	$6.00 ➝ $6.00	Buy ➝ Buy
GRAB Grab	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.89 +11.6%	$7.00 ➝ $8.00	Outperform ➝ Outperform
GSK GSK	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.52 -2.3%	$53.00 ➝ $39.50	Buy ➝ Hold
GTN Gray Television	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.39 -2.7%	$10.00 ➝ $8.00	Buy ➝ Buy
HAIN The Hain Celestial Group	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.68 -7.9%	$9.00 ➝ $8.00	Neutral ➝ Neutral
HBCP Home Bancorp	Downgraded by	Hovde Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$50.69 -1.7%	$53.00 ➝ $54.50	Outperform ➝ Market Perform
HGV Hilton Grand Vacations	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.19 +1.8%	$57.00 ➝ $55.00	Outperform ➝ Outperform
HMN Horace Mann Educators	Downgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.06 -0.6%	$39.00 ➝ $44.00	Outperform ➝ Market Perform
HMY Harmony Gold Mining	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.22 -1.5%	$8.20 ➝ $8.40	Neutral ➝ Neutral
HOOD Robinhood Markets	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.00 +0.6%	$33.00 ➝ $40.00	Market Outperform ➝ Market Outperform
HOT.UN American Hotel Income Properties REIT	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$0.64 +4.9%	C$0.60 ➝ C$0.80
HPK HighPeak Energy	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Dingmann Subscribe to MarketBeat All Access for the recommendation accuracy rating	$14.07 +0.6%	$12.00 ➝ $14.00	Hold ➝ Hold
HPP Hudson Pacific Properties	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.04 -9.0%	$5.50 ➝ $5.00	Buy ➝ Hold
HWM Howmet Aerospace	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.56 -1.0%	$113.00 ➝ $129.00	Overweight ➝ Overweight
IAC IAC	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.18 -12.6%	$110.00 ➝ $110.00	Buy ➝ Buy
IFF International Flavors & Fragrances	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$89.43 -2.0%	$111.00 ➝ $110.00	Equal Weight ➝ Overweight
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here
IHRT iHeartMedia	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.39 -4.0%	$1.00 ➝ $3.00	Underperform ➝ Neutral
ILMN Illumina	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$147.62 -2.6%	$156.00	Equal Weight
ILMN Illumina	Target Raised by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$147.62 -2.6%	$170.00 ➝ $184.00	Overweight ➝ Overweight
IMXI International Money Express	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.75 +0.7%	$22.00 ➝ $25.00	Buy ➝ Buy
IOBT IO Biotech	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.93 -11.5%	$12.00 ➝ $12.00	Buy ➝ Buy
IPAR Inter Parfums	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.00 -2.2%	$163.00 ➝ $163.00	Buy ➝ Buy
IPHA Innate Pharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.90 +2.7%	$11.50 ➝ $11.50	Buy ➝ Buy
IRON Disc Medicine	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.26 -5.0%	$75.00 ➝ $83.00	Outperform
ITOS iTeos Therapeutics	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.19 -2.0%	$25.00	Outperform
IVA Inventiva	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.64 -2.2%	$3.00	Neutral
IVAC Intevac	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.55 -22.8%		Hold
JBHT J.B. Hunt Transport Services	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$192.54 -2.4%	$204.00 ➝ $227.00	Buy ➝ Buy
JLL Jones Lang LaSalle	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$266.44 -2.5%	$280.00 ➝ $292.00	Market Perform ➝ Market Perform
KIM Kimco Realty	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.68 -1.5%	$23.00 ➝ $26.00	Outperform ➝ Outperform
KNX Knight-Swift Transportation	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$56.48 -4.1%	$56.00 ➝ $56.00	Neutral ➝ Sell
KOP Koppers	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.02 +0.7%	$64.00 ➝ $64.00	Outperform ➝ Outperform
KPRX Kiora Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.62 -3.2%	$10.00 ➝ $10.00	Buy ➝ Buy
KRG Kite Realty Group Trust	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.25 -0.7%	$28.00 ➝ $31.00	Overweight ➝ Overweight
L Loblaw Companies	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$187.39 +0.7%	C$183.00 ➝ C$205.00
LAC Lithium Americas	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.10 -3.1%	$4.50 ➝ $5.00	Buy ➝ Buy
LAZR Luminar Technologies	Target Lowered by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.13 +10.8%	$1.50 ➝ $1.00	Hold ➝ Hold
LGND Ligand Pharmaceuticals	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Miehm Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.74 -2.2%	$130.00 ➝ $140.00	Outperform ➝ Outperform
LIVN LivaNova	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$53.00 +2.3%	$75.00 ➝ $75.00	Buy ➝ Buy
LPX Louisiana-Pacific	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Mamtora Subscribe to MarketBeat All Access for the recommendation accuracy rating	$112.78 +0.4%	$99.00 ➝ $103.00	Market Perform ➝ Market Perform
LTRX Lantronix	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.54 -2.3%	$7.50 ➝ $5.00	Buy ➝ Buy
LYEL Lyell Immunopharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.17 -3.3%	$1.00 ➝ $1.00	Neutral ➝ Neutral
LYV Live Nation Entertainment	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.67 +4.7%	$108.00 ➝ $145.00	Buy ➝ Buy
LYV Live Nation Entertainment	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.67 +4.7%	$120.00 ➝ $155.00	Outperform ➝ Outperform
LYV Live Nation Entertainment	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.67 +4.7%	$130.00 ➝ $146.00	Buy ➝ Buy
LYV Live Nation Entertainment	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.67 +4.7%	$110.00 ➝ $150.00	Outperform ➝ Outperform
LYV Live Nation Entertainment	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$129.67 +4.7%	$132.00 ➝ $144.00	Buy ➝ Buy
MBLY Mobileye Global	Initiated by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.93 +1.7%	$16.00 ➝ $20.00	Buy ➝ Buy
MELI MercadoLibre	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1,977.39 +0.8%	$2,500.00 ➝ $2,200.00	Overweight ➝ Overweight
MLYS Mineralys Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.38 -10.3%	$30.00 ➝ $30.00	Buy ➝ Buy
MNDY monday.com	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$260.59 -5.3%	$300.00 ➝ $350.00	Buy ➝ Buy
MNDY monday.com	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$260.59 -5.3%	$265.00 ➝ $270.00	Neutral ➝ Neutral
MNDY monday.com	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$260.59 -5.3%	$300.00 ➝ $300.00	Neutral ➝ Neutral
MNDY monday.com	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$260.59 -5.3%	$295.00 ➝ $310.00	Buy ➝ Buy
MNST Monster Beverage	Target Raised by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.02 +0.5%	$55.00 ➝ $65.00	Buy
MPWR Monolithic Power Systems	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$644.10 -0.5%	$950.00 ➝ $950.00	Buy ➝ Buy
MREO Mereo BioPharma Group	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.10 -4.2%	$7.00 ➝ $7.00	Buy ➝ Buy
MRU Metro	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$87.68 +1.8%	C$84.00 ➝ C$90.00	Buy
MSGE Madison Square Garden Entertainment	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.68 -2.9%	$49.00 ➝ $48.00	Buy ➝ Buy
MTCH Match Group	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$30.88 -3.3%	$45.00 ➝ $43.00	Overweight ➝ Overweight
MTCH Match Group	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$30.88 -3.3%	$36.00 ➝ $33.00	Equal Weight ➝ Equal Weight
MYO Myomo	Target Raised by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Woo Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.99 +1.8%	$8.50 ➝ $9.00	Buy ➝ Buy
NCLH Norwegian Cruise Line	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.86 +0.1%	$19.00 ➝ $26.00	Underweight ➝ Underweight
NEPH Nephros	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.64 +1.9%	$5.00 ➝ $5.00	Speculative Buy ➝ Speculative Buy
NFG National Fuel Gas	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$61.29 -0.3%	$65.00 ➝ $64.00	Neutral ➝ Neutral
NGNE Neurogene	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.00 -44.1%	$54.00 ➝ $72.00	Outperform ➝ Outperform
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here
NGNE Neurogene	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.00 -44.1%	$49.00 ➝ $55.00	Buy ➝ Buy
NGNE Neurogene	Target Raised by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.00 -44.1%	$45.00 ➝ $72.00	Outperform ➝ Outperform
NGNE Neurogene	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Seigerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.00 -44.1%	$65.00 ➝ $60.00	Outperform ➝ Outperform
NGNE Neurogene	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.00 -44.1%	$44.00 ➝ $60.00	Buy ➝ Buy
NOW ServiceNow	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1,048.29 +1.2%	$1,050.00 ➝ $1,150.00	Overweight ➝ Overweight
NSC Norfolk Southern	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$267.45 -1.4%	$302.00 ➝ $316.00	Buy ➝ Buy
NTR Nutrien	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.00 -3.7%	$63.00 ➝ $61.00	Buy
NUTX Nutex Health	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.56 +34.6%	$45.00 ➝ $60.00	Buy ➝ Buy
NUTX Nutex Health	Target Raised by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Vendetti Subscribe to MarketBeat All Access for the recommendation accuracy rating	$37.56 +34.6%	$45.00 ➝ $50.00	Buy ➝ Buy
NUVL Nuvalent	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$90.99 -3.6%	$115.00	Outperform
NVAX Novavax	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.46 -6.1%	$19.00 ➝ $19.00	Buy ➝ Buy
NVDA NVIDIA	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$148.29 +2.1%	$140.00 ➝ $165.00	Outperform ➝ Outperform
NVDA NVIDIA	Initiated by	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		$148.29 +2.1%	$178.00	Buy
NVRO Nevro	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Turkaly Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.06 -4.9%		Market Perform
NVRO Nevro	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.06 -4.9%	$7.00 ➝ $7.00	Sector Perform ➝ Sector Perform
NVRO Nevro	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.06 -4.9%	$8.00 ➝ $7.00	Hold ➝ Hold
NVRO Nevro	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.06 -4.9%	$7.00 ➝ $6.00	Underweight ➝ Underweight
NVRO Nevro	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.06 -4.9%	$5.00 ➝ $6.00	Neutral ➝ Neutral
NWSA News	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.33 +0.3%	$36.00 ➝ $40.00	Buy ➝ Buy
ODFL Old Dominion Freight Line	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$226.32 -2.4%	$201.00 ➝ $241.00	Neutral ➝ Neutral
ODFL Old Dominion Freight Line	Downgraded by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$226.32 -2.4%		Buy ➝ Hold
OKTA Okta	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$78.22 -0.3%	$115.00 ➝ $85.00	Buy ➝ Hold
ONIT Onity Group	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. George Subscribe to MarketBeat All Access for the recommendation accuracy rating	$30.70 -1.0%	$40.00 ➝ $45.00	Outperform ➝ Outperform
ONON ON	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$52.63 -0.2%	$53.00 ➝ $53.00	Outperform ➝ Outperform
ORIC ORIC Pharmaceuticals	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.26 -0.4%	$20.00	Outperform
OS Onestream	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.50 -2.4%	$35.00 ➝ $37.00	Equal Weight ➝ Equal Weight
OXY Occidental Petroleum	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$50.29 -1.0%	$80.00 ➝ $68.00	Buy ➝ Buy
OXY Occidental Petroleum	Target Lowered by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$50.29 -1.0%	$85.00 ➝ $77.00	Buy ➝ Buy
OXY Occidental Petroleum	Target Raised by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Leggate Subscribe to MarketBeat All Access for the recommendation accuracy rating	$50.29 -1.0%	$73.00 ➝ $75.00	Buy ➝ Buy
OXY Occidental Petroleum	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$50.29 -1.0%	$53.00 ➝ $54.00	Hold ➝ Hold
PAAS Pan American Silver	Target Raised by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$30.64 +1.6%	C$40.75 ➝ C$44.25
PAHC Phibro Animal Health	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.06 -1.9%	$13.00 ➝ $20.00	Underweight ➝ Underweight
PAL Proficient Auto Logistics	Target Lowered by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Paris Subscribe to MarketBeat All Access for the recommendation accuracy rating	$9.25 -3.7%	$17.00 ➝ $15.00	Outperform ➝ Outperform
PAR PAR Technology	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.91 -0.3%	$59.00 ➝ $71.00	Neutral ➝ Neutral
PAR PAR Technology	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Palmer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$74.91 -0.3%	$69.00 ➝ $92.00	Buy ➝ Buy
PBR Petróleo Brasileiro S.A. - Petrobras	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.73 +0.8%	$15.40 ➝ $17.00	Buy ➝ Buy
PCRX Pacira BioSciences	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Prasad Subscribe to MarketBeat All Access for the recommendation accuracy rating	$16.80 -4.0%	$25.00 ➝ $17.00	Equal Weight ➝ Equal Weight
PCT PureCycle Technologies	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.66 -1.9%	$8.00 ➝ $15.00	Buy ➝ Buy
PH Parker-Hannifin	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$699.17 -1.3%	$520.00 ➝ $575.00	Hold ➝ Hold
PHUN Phunware	Target Lowered by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.34 -10.9%	$20.00 ➝ $13.00	Buy ➝ Buy
PHUN Phunware	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.34 -10.9%	$9.00 ➝ $6.00	Buy ➝ Neutral
PKST Peakstone Realty Trust	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.30 -4.7%	$13.00 ➝ $15.00	Hold ➝ Hold
PLYM Plymouth Industrial REIT	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.65 -5.8%	$26.00 ➝ $25.00	Outperform ➝ Outperform
POW Power Co. of Canada	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$46.87 +0.6%	C$42.00 ➝ C$49.00
PRA ProAssurance	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.12 -1.1%	$14.00 ➝ $18.00	Hold ➝ Hold
PRKS United Parks & Resorts	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.87 +0.2%	$72.00 ➝ $70.00	Buy ➝ Buy
PSA Public Storage	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$330.24 -2.0%	$381.00 ➝ $380.00	Overweight ➝ Overweight
QUIK QuickLogic	Target Lowered by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.39 -9.2%	$12.00 ➝ $10.00	Buy ➝ Buy
RAPT RAPT Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.74 -0.6%		Neutral
RAPT RAPT Therapeutics	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.74 -0.6%	$17.00 ➝ $4.00	Overweight ➝ Overweight
RARE Ultragenyx Pharmaceutical	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.84 -5.7%	$121.00 ➝ $121.00	Buy ➝ Buy
RCI.B Rogers Communications	Target Lowered by	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$49.91 +0.0%	C$77.00 ➝ C$67.00
RDFN Redfin	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.35 -5.1%	$7.00 ➝ $8.00	Neutral ➝ Neutral
REPL Replimune Group	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.19 -2.5%	$17.00 ➝ $17.00	Buy ➝ Buy
REXR Rexford Industrial Realty	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.39 -3.2%	$54.00 ➝ $50.00	Buy ➝ Buy
RIGL Rigel Pharmaceuticals	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.22 +9.1%	$40.00 ➝ $49.00	Buy ➝ Buy
RLJ RLJ Lodging Trust	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.94 +1.3%	$11.00 ➝ $12.00	Outperform ➝ Outperform
RNR RenaissanceRe	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$263.83 -0.4%	$316.00 ➝ $310.00	Outperform ➝ Outperform
ROST Ross Stores	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$140.31 -1.4%	$179.00 ➝ $152.00	Buy ➝ Neutral
RRR Red Rock Resorts	Reiterated by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$52.41 -0.2%	$67.00 ➝ $57.00	Outperform ➝ Outperform
RUN Sunrun	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.74 -4.8%	$18.00 ➝ $12.00	Hold ➝ Hold
RUS Russel Metals	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Tupholme Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$42.84 -0.8%	C$46.00 ➝ C$50.00	Buy
RXO RXO	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$27.79 -5.5%	$33.00 ➝ $33.00	Buy ➝ Neutral
RXO RXO	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.79 -5.5%	$16.00 ➝ $12.00	Negative ➝ Negative
S SentinelOne	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.72 +2.0%	$25.00 ➝ $32.00	Hold ➝ Buy
SABK South Atlantic Bancshares	Upgraded by	Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.91 +4.4%	$17.25	Neutral ➝ Buy
SAIA Saia	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$545.73 -2.2%	$534.00 ➝ $651.00	Buy ➝ Buy
SBGI Sinclair	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.58 -4.8%	$14.00 ➝ $16.00	Underweight ➝ Underweight
SDHC Smith Douglas Homes	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.11 -7.2%	$20.00	Neutral
SFTC Softchoice	Upgraded by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$21.31 +1.5%	C$20.00 ➝ C$24.00	Sector Perform ➝ Outperform
SGMT Sagimet Biosciences	Initiated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.94 +1.5%	$12.00	Buy
SHOP Shopify	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.24 +20.3%	$72.00 ➝ $115.00	Neutral
SLDB Solid Biosciences	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.51 -8.0%	$15.00 ➝ $12.00	Overweight ➝ Overweight
SLRC SLR Investment	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.97 -0.8%	$12.50 ➝ $13.00	Underweight ➝ Underweight
SNDR Schneider National	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$31.69 -0.4%	$32.00 ➝ $30.00	Neutral ➝ Sell
SNDX Syndax Pharmaceuticals	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.21 -25.6%	$47.00 ➝ $49.00	Buy ➝ Buy
SONY Sony Group	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.68 -2.3%	$108.00 ➝ $25.00	Outperform ➝ Outperform
SPNS Sapiens International	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.11 -3.4%	$38.00 ➝ $30.00	Underweight ➝ Underweight
SPNS Sapiens International	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.11 -3.4%	$44.00 ➝ $35.00	Buy ➝ Buy
SPRB Spruce Biosciences	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.53 -1.9%	$2.00 ➝ $2.00	Sector Perform ➝ Sector Perform
SQ Block	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.20 +4.5%	$95.00 ➝ $120.00	Buy ➝ Buy
SRRK Scholar Rock	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.66 -5.3%	$35.00 ➝ $40.00	Buy ➝ Buy
SSSS SuRo Capital	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.00 -4.8%	$6.00 ➝ $6.00	Outperform ➝ Outperform
SUI Sun Communities	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$124.18 -2.3%	$147.00 ➝ $114.00	Neutral ➝ Underperform
SWTX SpringWorks Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.10 -1.3%	$76.00 ➝ $74.00	Buy ➝ Buy
TALO Talos Energy	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.97 +1.7%	$20.00 ➝ $20.00	Buy ➝ Buy
TCBK TriCo Bancshares	Downgraded by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.38 -1.1%	$50.00 ➝ $53.00	Buy ➝ Neutral
TCOM Trip.com Group	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.02 -4.0%	$65.00 ➝ $78.00	Outperform ➝ Outperform
TCRX TScan Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Blum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.42 -4.9%	$11.00 ➝ $11.00	Buy ➝ Buy
TECX Tectonic Therapeutic	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Fauth Subscribe to MarketBeat All Access for the recommendation accuracy rating	$47.75 +3.6%	$55.00 ➝ $79.00	Overweight ➝ Overweight
TEM Tempus AI	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Westenberg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$68.04 -12.3%	$40.00 ➝ $70.00	Neutral ➝ Neutral
TFII TFI International	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$147.09 -0.6%	$158.00 ➝ $170.00	Buy ➝ Buy
TGLS Tecnoglass	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.93 -6.9%	$65.00 ➝ $90.00	Buy ➝ Buy
TGNA TEGNA	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.47 -1.0%	$16.00 ➝ $19.00	Neutral ➝ Neutral
TIMB TIM	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$14.31 -0.3%	$18.00 ➝ $17.50	Equal Weight ➝ Equal Weight
TOST Toast	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$39.42 +3.9%	$35.00 ➝ $44.00	Buy ➝ Buy
TOT Total Energy Services	Target Raised by	ATB Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$10.86 +2.0%	C$18.00 ➝ C$19.00
TPB Turning Point Brands	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$55.00 +4.8%	$45.00 ➝ $65.00	Buy ➝ Buy
TSHA Taysha Gene Therapies	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.39 +46.6%	$5.00 ➝ $5.00	Market Outperform ➝ Market Outperform
TSHA Taysha Gene Therapies	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.39 +46.6%	$7.00 ➝ $7.00	Overweight ➝ Overweight
TSHA Taysha Gene Therapies	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.39 +46.6%	$6.00 ➝ $6.00	Buy ➝ Buy
TSLX Sixth Street Specialty Lending	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.39 +0.0%	$23.00 ➝ $23.00	Outperform ➝ Outperform
TWLO Twilio	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$96.51 +2.6%	$80.00 ➝ $120.00	Equal Weight ➝ Overweight
UNCY Unicycive Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.48 -9.4%	$2.50 ➝ $2.50	Buy ➝ Buy
UNP Union Pacific	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$238.91 -1.3%	$255.00 ➝ $267.00	Neutral ➝ Neutral
UPS United Parcel Service	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$130.17 -1.1%	$163.00 ➝ $158.00	Buy ➝ Buy
VAC Marriott Vacations Worldwide	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$93.86 -0.3%	$110.00 ➝ $117.00	Outperform ➝ Outperform
VCSA Vacasa	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.25	$6.50 ➝ $5.00	Neutral ➝ Neutral
VCTR Victory Capital	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.74 -7.8%	$60.00 ➝ $68.00	Buy ➝ Buy
VEON VEON	Initiated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.34 +0.5%	$48.00	Buy
VIK Viking	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$45.85 +3.2%	$37.00 ➝ $49.00	Equal Weight ➝ Overweight
VLRS Controladora Vuela Compañía de Aviación	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.71 +2.4%	$16.50 ➝ $17.00	Overweight ➝ Overweight
VOYA Voya Financial	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$83.32 +0.1%	$90.00 ➝ $95.00	Outperform ➝ Outperform
VRE Veris Residential	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.23 +0.8%	$20.00 ➝ $23.00	Neutral ➝ Buy
VSCO Victoria's Secret & Co.	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.80 +2.4%	$30.00 ➝ $40.00	Buy ➝ Buy
WH Wyndham Hotels & Resorts	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$98.57 +1.5%	$90.00 ➝ $115.00	Outperform ➝ Outperform
WMT Walmart	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$85.01 +1.0%	$82.00 ➝ $89.00	Overweight ➝ Overweight
WN George Weston	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$233.56 +1.2%	C$230.00 ➝ C$253.00
WVE Wave Life Sciences	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.89 -3.3%	$17.00 ➝ $36.00	Buy ➝ Buy
XPO XPO	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Rosa Subscribe to MarketBeat All Access for the recommendation accuracy rating	$151.42 -2.4%	$155.00 ➝ $179.00	Buy ➝ Buy
ZETA Zeta Global	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.22 -23.2%	$35.00 ➝ $42.00	Buy ➝ Buy
ZETA Zeta Global	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.22 -23.2%	$33.00 ➝ $42.00	Outperform ➝ Outperform
ZETA Zeta Global	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.22 -23.2%	$36.00 ➝ $43.00	Buy ➝ Buy
ZETA Zeta Global	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.22 -23.2%	$35.00 ➝ $42.00	Buy ➝ Buy
ZETA Zeta Global	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.22 -23.2%	$37.00 ➝ $45.00	Buy ➝ Buy
ZETA Zeta Global	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.22 -23.2%	$39.00 ➝ $42.00	Buy ➝ Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:16 AM ET.

(Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

analyst ratings Headlines

Stock market today: World stocks mixed after Wall Street momentum slows with cooling Trump trade
By The Associated Press | November 12, 2024
View Stock market today: World stocks mixed after Wall Street momentum slows with cooling Trump trade
Trump's economic agenda for his second term is clouding the outlook for mortgage rates
By The Associated Press | November 12, 2024
View Trump's economic agenda for his second term is clouding the outlook for mortgage rates
How major US stock indexes fared Tuesday, 11/12/2024
By The Associated Press | November 12, 2024
View How major US stock indexes fared Tuesday, 11/12/2024
Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
By Thomas Hughes | November 12, 2024
View Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
Amazon: Why Analysts Think It's a Solid Buy Ahead of Earnings
By Sam Quirke | October 28, 2024
View Amazon: Why Analysts Think It's a Solid Buy Ahead of Earnings
J.B. Hunt Stock on the Move: Analysts Forecast Big Gains Ahead
By Thomas Hughes | October 17, 2024
View J.B. Hunt Stock on the Move: Analysts Forecast Big Gains Ahead
Salesforce: Have You Seen The Latest Price Target Upgrade?
By Sam Quirke | October 16, 2024
View Salesforce: Have You Seen The Latest Price Target Upgrade?

Top Headlines and Offers

View All

Top 3 Sectors Outperforming After Trump’s Victory
By Ryan Hasson | November 7, 2024
View Top 3 Sectors Outperforming After Trump’s Victory
3 "Made in America" Stocks to Benefit From the Trump Presidency
By Jea Yu | November 11, 2024
View 3 "Made in America" Stocks to Benefit From the Trump Presidency
625,000% Gain
From Crypto Swap Profits(Ad)
View 625,000% Gain
What a Trump Win Looks Like for the Market Now and Into 2025
By Thomas Hughes | November 6, 2024
View What a Trump Win Looks Like for the Market Now and Into 2025
2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
By Jea Yu | November 11, 2024
View 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
Is NVIDIA-Backed SoundHound AI a Buy Ahead of Nov. 12 Earnings?
By Leo Miller | November 6, 2024
View Is NVIDIA-Backed SoundHound AI a Buy Ahead of Nov. 12 Earnings?
Unveiled: NVIDIA’s "Secret Royalty" Program
From Behind the Markets(Ad)
View Unveiled: NVIDIA’s "Secret Royalty" Program
The Top 5 Performing S&P 500 Stocks YTD in 2024
By Ryan Hasson | November 8, 2024
View The Top 5 Performing S&P 500 Stocks YTD in 2024
Gilead’s Stock Surge: What’s Fueling the Momentum?
By Jeffrey Neal Johnson | November 7, 2024
View Gilead’s Stock Surge: What’s Fueling the Momentum?
Stock market today: Wall Street cruises to more records as it closes its best week in a year
By The Associated Press | November 7, 2024
View Stock market today: Wall Street cruises to more records as it closes its best week in a year
California Resources Stock Could Be a Huge Long-Term Winner
By Leo Miller | November 10, 2024
View California Resources Stock Could Be a Huge Long-Term Winner
Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
By Jeffrey Neal Johnson | November 8, 2024
View Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future

Stock Forecasts and Research Tools

Today's Ratings

Top Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings